The global fill finish manufacturing market is projected to grow from USD 18.36 billion in 2025 to USD 28.14 billion by 2030, ...
Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...
After a series of unfortunate regulatory rejections and manufacturing issues surfaced, Regeneron’s shares dipped to $483 this ...
The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...
Integrated isolators, sterilization technologies, and filling solutions deliver proven sterility, reliability, and efficiency ...
The global slip-tip syringe market is entering a phase of dynamic growth, as both long-standing manufacturers and a new ...
The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.
Macter International Limited announced on Thursday that it had obtained the requisite licenses for its Pre-Filled Syringe (PFS) and Pre-Filled Pen (PFP) manufacturing facilities within its biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback